3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
24
Neoplasms
15
Prostatic Neoplasms
12
Lung Neoplasms
11
Uterine Cervical Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
6
Pancreatic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Head and Neck Neoplasms
5
Stomach Neoplasms
4
Rectal Neoplasms
4
Carcinoma, Squamous Cell
4
Carcinoma, Basal Cell
4
Uterine Cervical Dysplasia
3
Skin Neoplasms
3
Melanoma
3
Glioma
3
Glioblastoma
3
Esophageal Neoplasms
3
Disease
3
Colorectal Neoplasms
3
Central Nervous System Neoplasms
3
Carcinoma, Intraductal, Noninfiltrating
3
Breast Neoplasms, Male
3
Breast Carcinoma In Situ
3
Barrett Esophagus
3
Thyroid Neoplasms
2
Sarcoma
2
Precancerous Conditions
2
Oligodendroglioma
2
Interventions
Human Papillomavirus DNA Tests
6
Colposcopy
6
Educational Status
5
Specimen Handling
4
Early Intervention, Educational
4
Vaginal Smears
3
Surveys and Questionnaires
3
Patient Navigation
3
Methods
3
epigallocatechin gallate
2
Vitamin B 12
2
Transurethral Resection of Prostate
2
Standard of Care
2
Practice Guidelines as Topic
2
Motivational Interviewing
2
Mass Screening
2
Electrocoagulation
2
Watchful Waiting
1
Triage
1
Telemedicine
1
Standing Orders
1
Referral and Consultation
1
Radiotherapy, Intensity-Modulated
1
Pregnancy Tests
1
Papanicolaou Test
1
Nimorazole
1
Mindfulness-Based Stress Reduction
1
Lacteol
1
Interviews as Topic
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Papillomavirus Infections
×
Biopsy
×
Clear all
NCT04072913
2019-08-28
MMP-HPV
University Hospital, Bordeaux
Phase NA
Completed
216 enrolled